Overview

Study to Evaluate Safety, Tolerability & PK of rhNGF in Healthy Volunteers

Status:
Completed
Trial end date:
2018-06-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to assess the safety and tolerability of a single short-term and a multiple dose scheme of rhNGF when administered as eye drops in healthy subjects of Japanese ethnicity. The secondary objective of this study is to assess the pharmacokinetics of single and multiple doses of rhNGF when administered as eye drops in healthy subjects of Japanese ethnicity.
Phase:
Phase 1
Details
Lead Sponsor:
Dompé Farmaceutici S.p.A
Collaborator:
Cromsource